:

Katja C Heinz1, Charlotte Beaudart2, Damon Willems2

  • 1Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands. katja.heinz@maastrichtuniversity.nl.

PharmacoEconomics
|July 1, 2023
PubMed
概括

针对阿托皮性皮炎 (AD) 的新兴疗法显示出不同的成本效益. 虽然大多数治疗方法都具有成本效益,但研究设计的不一致性阻碍了政策决策的直接比较.